High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection.
作者信息
Cappellano Giuseppe, Abreu Hugo, Raineri Davide, Scotti Lorenza, Castello Luigi, Vaschetto Rosanna, Chiocchetti Annalisa
出版信息
EMBO Mol Med. 2021 Nov 8;13(11):e15217. doi: 10.15252/emmm.202115217.
Abstract
摘要
相似文献
1
High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection.无论是否感染新冠病毒，炎症性肺病患者循环骨桥蛋白水平均较高。
EMBO Mol Med. 2021 Nov 8;13(11):e15217. doi: 10.15252/emmm.202115217.
2
High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection.炎症性肺病患者循环骨桥蛋白水平升高，与 SARS-CoV-2 感染无关。
EMBO Mol Med. 2021 May 7;13(5):e14124. doi: 10.15252/emmm.202114124. Epub 2021 Mar 31.
3
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection.超越预测：揭示 μ 阿片受体和大麻素受体以及免疫介质在评估 SARS-CoV-2 感染严重程度方面的预后能力。
BMC Infect Dis. 2024 Apr 12;24(1):398. doi: 10.1186/s12879-024-09280-6.
4
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.新型冠状病毒感染小鼠肺部的细胞因子和炎症脂质介质。
Front Immunol. 2022 Jun 24;13:893792. doi: 10.3389/fimmu.2022.893792. eCollection 2022.
5
Induction of a cytokine storm involves suppression of the Osteopontin-dependent TH1 response.细胞因子风暴的诱导涉及抑制骨桥蛋白依赖的 TH1 反应。
Immunology. 2022 Oct;167(2):165-180. doi: 10.1111/imm.13524. Epub 2022 Aug 10.
6
Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.循环钙卫蛋白作为鉴别 SARS-CoV-2 感染的支持性炎症标志物：一项观察性研究。
Inflamm Res. 2021 Jun;70(6):687-694. doi: 10.1007/s00011-021-01465-y. Epub 2021 May 6.
7
Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.宿主 miRNA-223-3p 对 SARS-CoV 诱导的肺部炎症病理的贡献。
mBio. 2022 Apr 26;13(2):e0313521. doi: 10.1128/mbio.03135-21. Epub 2022 Mar 1.
8
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection.基线T细胞免疫表型可预测SARS-CoV感染后的病毒学和疾病控制情况。
bioRxiv. 2020 Sep 21:2020.09.21.306837. doi: 10.1101/2020.09.21.306837.
9
Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2.评估心血管代谢暴露对循环蛋白的影响，这些蛋白可能导致严重的 SARS-CoV-2 感染。
EBioMedicine. 2021 Feb;64:103228. doi: 10.1016/j.ebiom.2021.103228. Epub 2021 Feb 3.
10
COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.COVID-19 相关肺微血管内皮病变：从基础研究角度看。
Am J Respir Crit Care Med. 2022 Oct 15;206(8):961-972. doi: 10.1164/rccm.202107-1774OC.
引用本文的文献
1
Organokines in COVID-19: A Systematic Review.COVID-19 中的器官激酶：系统评价。
Cells. 2023 May 9;12(10):1349. doi: 10.3390/cells12101349.
2
Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma.循环骨桥蛋白水平升高促进原发性肿瘤生长，但不会诱导黑色素瘤转移。
Biomedicines. 2023 Mar 28;11(4):1038. doi: 10.3390/biomedicines11041038.
3
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters.COVID-19 生物标志物在患者分层和靶向治疗之间的十字路口：经过验证和提出的参数的作用。
Int J Mol Sci. 2023 Apr 12;24(8):7099. doi: 10.3390/ijms24087099.
4
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.基线血浆骨桥蛋白蛋白升高预示住院 COVID-19 患者不良结局。
Viruses. 2023 Feb 25;15(3):630. doi: 10.3390/v15030630.
5
Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure.鉴定出肾脏损伤释放的循环骨桥蛋白是呼吸衰竭的致病因素。
Sci Adv. 2022 Feb 25;8(8):eabm5900. doi: 10.1126/sciadv.abm5900.
6
Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study.骨桥蛋白作为 COVID-19 严重程度和儿童多系统炎症综合征的生物标志物：一项初步研究。
Exp Biol Med (Maywood). 2022 Jan;247(2):145-151. doi: 10.1177/15353702211046835. Epub 2021 Sep 26.
7
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19.新冠病毒病住院患者的循环骨桥蛋白水平与预后
J Clin Med. 2021 Aug 30;10(17):3907. doi: 10.3390/jcm10173907.
Zotero 插件